Navigation Links
Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
Date:11/20/2012

SAN DIEGO, Nov. 20, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 24th Annual Piper Jaffray Healthcare Conference in New York.

The live presentation takes place on Tuesday, November 27 at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences Reports Third Quarter 2012 Results
2. Neurocrine Biosciences Reports Second Quarter 2012 Results
3. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
4. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
5. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
6. Amarantus BioSciences Wins MANF Patent Challenge in Europe
7. Amarantus BioSciences Issues CEO Letter to Shareholders
8. Amarantus BioSciences Secures $1.1 Million in Financing
9. IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
10. Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
11. Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/2/2019)... ... October 31, 2019 , ... ... Biotechnologies in a live webinar on Friday, November 15, 2019 ... , Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell receptors ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality ... Silver sponsorship and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) ... Diego, California. , The Biomanufacturing World Summit brings together pharmaceutical executives, ...
(Date:10/22/2019)... ... October 22, 2019 , ... Enplug , ... Mass Notification System into its digital signage platform. The collaboration brings one of ... possible for users to leverage their existing digital signage networks to quickly disseminate ...
(Date:10/10/2019)... (PRWEB) , ... October 09, 2019 , ... ... Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker ... October 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and ...
Breaking Biology Technology:
(Date:10/30/2019)... ... October 30, 2019 , ... The 2019 Precision Agriculture ... which participants will learn about precision agriculture tools used to enhance beef and ... , Participants will have the opportunity to visit Virginia Tech’s agricultural research center, ...
(Date:10/29/2019)... (PRWEB) , ... October 29, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one ... Bioprocess® platform to support the development and manufacturing of therapeutic proteins ...
(Date:10/26/2019)... ... 24, 2019 , ... World Cord Blood Day (WCBD) takes place on November ... learn about the current and future uses of cord blood stem cells, and the ... to treat and cure over 80 different life-threatening diseases, including leukemia, lymphoma, and sickle ...
Breaking Biology News(10 mins):